Drug Discovery Informatics Market Size, Share, Growth & Trends Forecast
IMARC Group, a leading market research company, has recently released a report titled “Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the drug discovery informatics market trends, share, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global drug discovery informatics market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032.
Request to Get the Sample Report:
https://www.imarcgroup.com/drone-packaging-delivery-market/requestsample
Global Drug Discovery Informatics Market
Drug discovery informatics is a pivotal domain within the pharmaceutical and life sciences industries, revolutionizing the process of developing new medications. It encompasses the utilization of computational techniques and advanced software solutions to expedite and enhance drug discovery. This dynamic field plays a critical role in the identification and optimization of potential drug candidates, significantly reducing the time and resources required for research and development.
Drug Discovery Informatics employs a comprehensive range of tools, algorithms, and databases to analyze biological data, predict molecular interactions, and simulate drug behavior. It has become an indispensable asset for pharmaceutical companies, research institutions, and biotechnology firms, propelling innovation in drug design and efficacy assessment.
Global Drug Discovery Informatics Market Trends:
The global drug discovery informatics market is primarily being driven by the increasing demand for more efficient drug discovery processes. Pharmaceutical companies are under constant pressure to bring new drugs to market quickly, and Drug Discovery Informatics offers a solution by streamlining research efforts.
Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) algorithms into informatics platforms is a prominent trend. These technologies empower researchers to analyze vast datasets, identify potential drug candidates, and predict their biological interactions with unparalleled accuracy.
Additionally, the widespread adoption of cloud-based informatics solutions is acting as a major growth-inducing factor. Drug discovery informatics enables the customization of drug development strategies based on individual patient profiles, enhancing the efficacy and safety of treatments.
Moreover, regulatory authorities are becoming more receptive to data generated through informatics approaches, paving the way for smoother approvals. This, in turn, is creating a positive outlook for the market further across the globe.
Drug Discovery Informatics Market Segments:
Breakup by Workflow:
· Drug Discovery
· Drug Development
Breakup by Function:
· Sequence Analysis Platforms
· Molecular Modelling
· Molecular Docking
· Clinical Trial Data Management
· Others
Breakup by Mode:
· Outsourced
· In-house
Breakup by End User:
· Pharmaceutical Companies
· Biotechnology Companies
· Contract Research Organization (CROs)
· Others
Breakup by Region:
· North America
· Europe
· Asia-Pacific
· Other Regions
Competitive Landscape with Key Players:
The competitive landscape of the drug discovery informatics market size has been studied in the report with the detailed profiles of the key players operating in the market.
Some of These Key Players Include:
· Accenture Plc
· Certara
· Charles River Laboratories Inc.
· Collaborative Drug Discovery Inc.
· Eurofins DiscoverX Products
· Infosys Ltd.
· International Business Machines Corporation
· Jubilant Biosys Limited
· Oracle Corporation
· PerkinElmer Inc.
· Selvita
· Thermo Fisher Scientific Inc.
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=report&id=3515&flag=C
Key Highlights of the Report:
· Market Performance (2018-2023)
· Market Outlook (2024-2032)
· Market Trends
· Market Drivers and Success Factors
· Impact of COVID-19
· Value Chain Analysis
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: imarcgroup.com
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian